I agree that this site is using cookies. You can find further informations here.
X
Ruth Plummer
289  results:
Search for persons X
?
1

A three-arm randomised phase II study of the MEK inhibitor ..:

Sacco, Joseph J. ; Jackson, Richard ; Corrie, Pippa...
European Journal of Cancer.  202 (2024)  - p. 114009 , 2024
Link: https://doi.org/10.1016/..
 
?
2

OTHR-06. A NEW INTERNATIONAL, MULTIDISCIPLINARY ACCELERATOR..:

Aitken, Charlotte ; Huskens, Nicky ; Bushby, Katie...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
3

First-in-Human Study of the Ataxia Telangiectasia and Rad3-..:

Yap, Timothy A. ; Tolcher, Anthony W. ; Plummer, Ruth...
Clinical Cancer Research.  30 (2024)  10 - p. 2057-2067 , 2024
Link: https://doi.org/10.1158/..
 
?
4

Early switch from intravenous to oral antibiotic therapy in..:

Coyle, Vicky ; Forde, Caroline ; Adams, Richard...
Health Technology Assessment.  , 2024
Link: https://doi.org/10.3310/..
 
?
5

Early switch to oral antibiotic therapy in patients with lo..:

Coyle, Vicky ; Forde, Caroline ; McAuley, Danny F....
Clinical Microbiology and Infection.  30 (2024)  1 - p. 92-99 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Monitoring immunE DysregulAtion foLLowing Immune checkpOint..:

Gault, Abigail ; Hogarth, Linda ; Williams, Kristian C...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
7

Ataxia telangiectasia and Rad3-related (ATR) inhibitor camo..:

Fontana, Elisa ; Rosen, Ezra ; Lee, Elizabeth K...
JNCI: Journal of the National Cancer Institute.  , 2024
Link: https://doi.org/10.1093/..
 
?
8

Histology independent drug development – Is this the future..:

Billingham, Lucinda ; Brown, Lynn ; Framke, Theodor...
Cancer Treatment Reviews.  123 (2024)  - p. 102674 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Combining PARP Inhibitors and Androgen Receptor Signalling ..:

Messina, Carlo ; Giunta, Emilio Francesco ; Signori, Alessio...
European Urology Oncology.  7 (2024)  2 - p. 179-188 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Nilotinib in KIT-driven advanced melanoma: Results from the..:

Larkin, James ; Marais, Richard ; Porta, Nuria...
Cell Reports Medicine.  5 (2024)  3 - p. 101435 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Olaparib plus Durvalumab, with or without Bevacizumab, as T..:

Drew, Yvette ; Kim, Jae-Weon ; Penson, Richard T....
Clinical Cancer Research.  30 (2023)  1 - p. 50-62 , 2023
Link: https://doi.org/10.1158/..
 
?
12

Camonsertib in DNA damage response-deficient advanced solid..:

Yap, Timothy A. ; Fontana, Elisa ; Lee, Elizabeth K....
Nature Medicine.  29 (2023)  6 - p. 1400-1411 , 2023
Link: https://doi.org/10.1038/..
 
?
13

A Phase 1/2A trial of idroxioleic acid: first-in-class sphi..:

Lopez, Juanita ; Lai-Kwon, Julia ; Molife, Rhoda...
British Journal of Cancer.  129 (2023)  5 - p. 811-818 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Programmed cell death-1 receptor-mediated regulation of Tbe..:

Lim, Jing Xuan ; Lai, Chester Y. ; Mallett, Grace E....
Proceedings of the National Academy of Sciences.  120 (2023)  18 - p. , 2023
Link: https://doi.org/10.1073/..
 
?
15

Immune-related adverse events in checkpoint blockade: Obser..:

Williams, Kristian C. ; Gault, Abigail ; Anderson, Amy E....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15